Literature DB >> 15659365

Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step.

Erick K Dufour1, Antoine Désilets, Jean-Michel Longpré, Richard Leduc.   

Abstract

Furin proteolytically cleaves a wide variety of proprotein substrates mainly within the trans-Golgi network (TGN) but also at the cell membrane and in endosomal compartments where pH is more acidic. Incorporation of furin recognition sequences within the reactive site loop (RSL) of alpha(1)-antitrypsin (AT) leads to the production of furin inhibitors. In an attempt to design more stable, potent, and specific serpin-based inhibitors, we constructed a series of AT and alpha(1)-antichymotrypsin (ACT) mutants by modifying the P(7)-P(1) region of their RSLs. The biochemical properties of these variants were assessed by evaluating their propensity to establish SDS-resistant complexes with furin in a variety of conditions (pH 6.0-9.0) and by measuring their association rate constants. The effect of pH during the initial steps of complex formation was minimal, suggesting that the acylation step is not rate-limiting. The decrease in stoichiometry of inhibition (SI) values observed in AT variants at high pHs was a result of the reduced pH-dependent deacylation rate, which is rate-limiting in this mechanism and which suggests increased complex stability. Conversely, the SI values for ACT mutants had a tendency to be lower at acidic pH. Transiently transfecting HEK293 cells with these mutants abolished processing of the pro-von Willebrand factor precursor but, interestingly, only the ACT variants were secreted in the media as uncleaved forms. Our results suggest that reengineering the reactive site loops of serpins to accommodate and target furin or other serine proteases must take into account the intrinsic physicochemical properties of the serpin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659365      PMCID: PMC2253415          DOI: 10.1110/ps.04843305

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

Review 1.  Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications.

Authors:  F Bergeron; R Leduc; R Day
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

2.  Application of linear free energy relationships to the serpin-proteinase inhibition mechanism.

Authors:  P Nash; G McFadden; A Whitty
Journal:  FEBS Lett       Date:  2000-06-09       Impact factor: 4.124

3.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown.

Authors:  Michael I Plotnick; Madhurika Samakur; Zhi Mei Wang; Xhuzuo Liu; Harvey Rubin; Norman M Schechter; Trevor Selwood
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

Review 5.  Biosynthesis, processing and secretion of von Willebrand factor: biological implications.

Authors:  T R de Wit; J A van Mourik
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

6.  The contribution of arginine residues within the P6-P1 region of alpha 1-antitrypsin to its reaction with furin.

Authors:  E K Dufour; J B Denault; L Bissonnette; P C Hopkins; P Lavigne; R Leduc
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

7.  The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium.

Authors:  S V Calugaru; R Swanson; S T Olson
Journal:  J Biol Chem       Date:  2001-06-12       Impact factor: 5.157

8.  Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin.

Authors:  T Komiyama; R S Fuller
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

9.  Polyarginines are potent furin inhibitors.

Authors:  A Cameron; J Appel; R A Houghten; I Lindberg
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

10.  Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor.

Authors:  D Johnson; J Travis
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

View more
  5 in total

1.  The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin.

Authors:  Danielle M Williamson; Johannes Elferich; Parvathy Ramakrishnan; Gary Thomas; Ujwal Shinde
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 2.  Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques.

Authors:  Benjamin M Scott; William P Sheffield
Journal:  Protein Sci       Date:  2019-12-09       Impact factor: 6.725

3.  The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).

Authors:  Imène Kara; Marjorie Poggi; Bernadette Bonardo; Roland Govers; Jean-François Landrier; Sun Tian; Ingo Leibiger; Robert Day; John W M Creemers; Franck Peiretti
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

4.  Genetic analysis of fin development in zebrafish identifies furin and hemicentin1 as potential novel fraser syndrome disease genes.

Authors:  Thomas J Carney; Natália Martins Feitosa; Carmen Sonntag; Krasimir Slanchev; Johannes Kluger; Daiji Kiyozumi; Jan M Gebauer; Jared Coffin Talbot; Charles B Kimmel; Kiyotoshi Sekiguchi; Raimund Wagener; Heinz Schwarz; Phillip W Ingham; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2010-04-15       Impact factor: 5.917

5.  Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin.

Authors:  Benjamin M Scott; Wadim L Matochko; Richard F Gierczak; Varsha Bhakta; Ratmir Derda; William P Sheffield
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.